Research output per year
Research output per year
-
Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy
Gong, Y., Wolterink, R. G. J. K., Wang, J. X., Bos, G. M. J. & Germeraad, W. T. V., 1 May 2021, In: Journal of Hematology & Oncology. 14, 1, 35 p., 73.Research output: Contribution to journal › (Systematic) Review article › peer-review
Open Access -
Defucosylation of Tumor-Specific Humanized Anti-MUC1 Monoclonal Antibody Enhances NK Cell-Mediated Anti-Tumor Cell Cytotoxicity
Gong, Y., Klein Wolterink, R. G. J., Gulaia, V., Cloosen, S., Ehlers, F. A. I., Wieten, L., Graus, Y. F., Bos, G. M. J. & Germeraad, W. T. V., Jun 2021, In: Cancers. 13, 11, 19 p., 2579.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Rosuvastatin Enhances VSV-G Lentiviral Transduction of NK Cells via Upregulation of the Low-Density Lipoprotein Receptor
Gong, Y., Wolterink, R. G. J. K., Janssen, I., Groot, A. J., Bos, G. M. J. & Germeraad, W. T. V., 12 Jun 2020, In: Molecular Therapy - Methods and Clinical Development. 17, p. 634-646 13 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Influence of Vitamin C on Lymphocytes: An Overview
van Gorkom, G. N. Y., Wolterink, R. G. J. K., Van Elssen, C. H. M. J., Wieten, L., Germeraad, W. T. V. & Bos, G. M. J., 10 Mar 2018, In: Antioxidants. 7, 3, 14 p., 41.Research output: Contribution to journal › (Systematic) Review article › peer-review
Open Access